Search
for
Sort by
Research 121–150 of 212
- Understanding the Intricate Pathophysiology of Psoriasis and Related Skin Disorders
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Unveiling the Effect of Age and IgE Level on Alopecia Areata: Insights from Comparative RNAseq Analysis
- The Role of Linoleic Acid in Skin and Hair Health: A Review
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Tracing immune cells around biomaterials with spatial anchors during large-scale wound regeneration
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- Understanding autoimmunity of vitiligo and alopecia areata
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Alopecia Areata: Current Treatments and New Directions
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Metabolic Syndrome and Skin Diseases
- Alopecia Areata: An Autoimmune Disease of Multiple Players
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Optimization and Characterization of TSG-Enriched Polygonum multiflorum Extract and Its Dual Mechanism Against Androgenetic Alopecia via 5α-Reductase Inhibition and Wnt/β-Catenin Activation
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Detection of subtypes of T helper cells and their cytokines in peripheral blood of patients with systematic lupus erythematosus and their clinical significances
- Probiotic Bacteria Induce a ‘Glow of Health’
- Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review
- Mechanism of Sleep Disturbance in Children with Atopic Dermatitis and the Role of the Circadian Rhythm and Melatonin
- Alopecia areata in 2 patients treated with dupilumab: New onset and worsening
- Newborn infant skin gene expression: Remarkable differences versus adults